Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diagnos (TSE:ADK)
TSXV:ADK
Diagnos (ADK) Stock Price & Analysis
19 Followers
ADK Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.23 - C$0.59
Previous CloseC$0.32
Volume57.51K
Average Volume (3M)80.41K
Market Cap
C$26.06M
Enterprise ValueC$28.95M
Total Cash (Recent Filing)C$305.20K
Total Debt (Recent Filing)C$3.20M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Aug 22, 2024EPS Estimate
-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding76,648,586
10 Day Avg. Volume91,791
30 Day Avg. Volume80,407
Standard Deviation0.22
R-Squared0.00866
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-8.51
Price to Sales (P/S)47.88
Price to Cash Flow (P/CF)-9.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Diagnos News
PremiumCompany Announcements
DIAGNOS Completes Final Private Placement Round
PremiumCompany Announcements
DIAGNOS and Labtician Bolster Diabetic Eye Care
PremiumCompany Announcements
DIAGNOS Inc. Advances AI Health Tech with Funding
PremiumCompany Announcements
Diagnos Inc Unveils AI Breakthroughs in Eye HealthBulls Say, Bears Say
Bulls Say
Market ReachThe deal with EssilorLuxottica provides DIAGNOS with access to approximately 18,000 optical retail locations globally, enhancing its market reach.
Quebec RFPDIAGNOS is best positioned to win the AI-based screening component of the Quebec RFP, which could be a significant catalyst for the stock.
Technology IntegrationADK’s equipment-agnostic platform integrates seamlessly with existing optometry cameras and workflows to enable early detection, grading, and monitoring of Diabetic Retinopathy.
Bears Say
Expansion IssuesADK continues to experience delays in its New Look roll-out, with only 50 locations online.
Operational HurdlesADK continues to experience delays in its New Look roll-out, with only 50 locations online.
Project DelaysADK continues to experience delays in its New Look roll-out, with only 50 locations online.
---
Options Prices
Currently, No data available
---
Ownership Overview
69.33% Insiders
0.00% Mutual Funds
0.37% Other Institutional Investors
30.30% Public Companies and
Individual Investors
ADK FAQ
What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.23 and its highest was C$0.59 in the past 12 months.
What is Diagnos’s market cap?
Currently, no data Available
When is Diagnos’s upcoming earnings report date?
Diagnos’s upcoming earnings report date is Aug 22, 2024 which is in 36 days.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on Jun 06, 2024. The company reported -C$0.01 earnings per share for the quarter, the consensus estimate of -C$0.01 by C$0.
Is Diagnos overvalued?
According to Wall Street analysts Diagnos’s price is currently Overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate is -C$0.01.
How many shares outstanding does Diagnos have?
Diagnos has 81,435,610 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.01 in its last earnings report, expectations of -C$0.01. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
---
Diagnos Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Diagnos
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, US, UAE, Saudi Arabia and others. The company's key revenue is derived from Canada.
---
ADK Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ADK
1 Year
1 Year Success Rate
9/21 ratings generated profit
1 Year Average Return
+17.91%
assigned a buy rating 4 months ago
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +17.91% per trade.
---